Cellectis (CLLS) Tax Rate (2022 - 2026)

Cellectis (CLLS) posted quarterly Tax Rate of 0.52% for Q1 2026, up 7.49% quarter-over-quarter from 0.48% in Q4 2025.

Cellectis (CLLS) Tax Rate (2022 - 2026) Analysis & Trends

Cellectis' Tax Rate history runs 5 years deep, the most recent figure standing at 0.52% for Q1 2026.

In Q1 2026, Tax Rate changed N/A year-over-year to 0.52%; the TTM figure through Mar 2026 stood at 0.73% (up 27.0% YoY), while the FY2025 annual figure was 0.62%, changed N/A from the prior year.
Tax Rate for Q1 2026 stood at 0.52%, up from 0.48% in the prior quarter.
The five-year high for Tax Rate was 3.07% in Q4 2022, with the low at 8.31% in Q2 2023.
The 5-year median for Tax Rate is 0.5% (2025), against an average of 0.13%.
The sharpest annual moves came in 2023 and 2024: Tax Rate sank 390 bps in 2023, then soared 756 bps in 2024.
Cellectis' Tax Rate stood at 3.07% in 2022, then slumped by 127 bps to 0.84% in 2023, then soared by 247 bps to 1.23% in 2024, then sank by 61 bps to 0.48% in 2025, then increased by 7 bps to 0.52% in 2026.
Business Quant data shows CLLS's Tax Rate at 0.52% in Q1 2026, 0.48% in Q4 2025, and 1.23% in Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Tax Rate (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	20.98%
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	15.11%
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	10.91%
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	24.15%
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-9.47%
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	7.49%
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	-16.71%
10	Cellectis	306.61 Mn	120.95 Mn	-	0.52%

Download Data